ALEMBIC PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Quarterly Results    (APLL)

Here are the latest quarterly results of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA financial fact sheet and ALEMBIC PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

ALEMBIC PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m8,62511,27110,1829,2709,48912,40912,09112,068 
Other income Rs m124353433449 
Turnover Rs m8,62611,29410,2179,3039,52212,41212,09512,077 
Expenses Rs m7,1158,2477,7597,4897,2408,9548,8418,793 
Gross profit Rs m1,5103,0232,4221,7831,9643,4553,2513,167 
Depreciation Rs m276286291300354360418441 
Interest Rs m1658605150717477 
Profit before tax Rs m1,2202,7032,1081,4671,5933,0292,7632,657 
Tax Rs m315703400149360525486621 
Profit after tax Rs m9042,0001,7081,3181,2332,5042,2772,035 
Gross profit margin %17.526.823.819.220.727.826.926.2 
Effective tax rate %25.926.019.010.222.617.317.623.4 
Net profit margin %10.517.716.814.213.020.218.816.9 
Diluted EPS Rs 4.8 10.6 9.1 7.0 6.5 13.3 12.1 10.8  
Diluted EPS (TTM) Rs 23.8 27.8 29.9 31.4 33.2 35.9 38.9 42.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: ALEMBIC PHARMA 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   STRIDES PHARMA SCIENCE  PIRAMAL ENTERPRISES  INDOCO REMEDIES  TTK HEALTHCARE  PANACEA BIOTECH  

Compare ALEMBIC PHARMA With:   STRIDES PHARMA SCIENCE  PIRAMAL ENTERPRISES  INDOCO REMEDIES  TTK HEALTHCARE  PANACEA BIOTECH  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

India's Import Embargo on Defence Items, June Quarter Results, and Top Buzzing Stocks Today(Pre-Open)

Extending gains to the third straight day, Indian share markets witnessed buying interest throughout the day yesterday, amid sustained foreign fund inflows and positive cues from global markets.

Views on news

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver? (Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

This 20 Year Cycle Suggests Gold is Set for an August Rally (Profit Hunter)

Jul 31, 2020

The real reason why gold prices will go up more.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 10, 2020 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS